Immunohistochemistry (IHC) Market

F. Hoffmann-La Roche Ltd (Switzerland) and Agilent Technologies, Inc. (US) are Leading Players in the Immunohistochemistry/IHC Market

The global immunohistochemistry market is projected to reach USD 2.7  billion by 2025 from USD 1.9 billion in 2020, at a CAGR of 6.6% during the forecast period. The increasing incidence and prevalence of cancer, technological advancements in IHC, and the availability of reimbursement for IHC tests are the major factors driving the growth of this market.

The prominent players operating in the IHC market are F. Hoffmann-La Roche Ltd (Switzerland), Agilent Technologies, Inc. (US), Danaher Corporation (US),  PHC Holding Corporation (Japan), Biocare Medical, LLC (US), and  Merck KGaA (Germany).

To know about the assumptions considered for the study download the pdf brochure

F. Hoffmann-La Roche Ltd (Switzerland) is the leading player in the immunohistochemistry market. The company has revolutionized cancer diagnostics across the globe through its cutting-edge testing automation. Its portfolio of more than 250 cancer tests and associated instruments makes it the leading global supplier of cancer diagnostic systems, including IHC products, to the pathology market. Strategically, the company focuses on obtaining US FDA and CE approvals to provide its products to various healthcare settings. Through US FDA and CE approvals for the VENTANA MMR IHC panel and VENTANA ALK D5F3 CDX assay, the company established its footprints in the immunohistochemistry market.

Agilent Technologies, Inc. (US) is well-positioned in the immunohistochemistry market and focuses on developing innovative diagnostic and therapeutic solutions to combat the rising incidence of infectious diseases, genetic disorders, and cancer. Over the years, the company has focused on launching new products for cancer diagnostic applications. Its standard staining protocols for FLEX RTU antibodies, combined with integrated instrument and software platforms, provide consistent and reliable results. This makes them the ideal choice for labs and academic end users

Related Reports:

Immunohistochemistry/IHC Market by Product (Antibodies, Reagents (Chromogenic Substrates), Kits), Application (Diagnostics (Cancer, Infectious), Research, Forensic), End User (Hospitals, Diagnostic Laboratories, Academic) - Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
BT 4780
RI Published ON
7/27/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Immunohistochemistry (IHC) Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved